Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-VEGFA Antibody (9C236) (Synonyms: VPF, VEGF-A, VEGF, MVCD1, L-VEGF)

Catalog No. TMAY-00344 Copy Product Info
🥰Excellent
Anti-VEGFA Antibody (9C236) is a Mouse antibody targeting VEGFA. Anti-VEGFA Antibody (9C236) can be used in IHC-P.

Anti-VEGFA Antibody (9C236)

Copy Product Info
🥰Excellent
Catalog No. TMAY-00344
Synonyms VPF, VEGF-A, VEGF, MVCD1, L-VEGF

Anti-VEGFA Antibody (9C236) is a Mouse antibody targeting VEGFA. Anti-VEGFA Antibody (9C236) can be used in IHC-P.

Anti-VEGFA Antibody
(9C236)
Pack SizePriceUSA StockGlobal StockQuantity
100 μL$1997-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-VEGFA Antibody (9C236) is a Mouse antibody targeting VEGFA. Anti-VEGFA Antibody (9C236) can be used in IHC-P.
SynonymsVPF, VEGF-A, VEGF, MVCD1, L-VEGF
Ig Type
Mouse IgG3
Clone
9C236
Reactivity
Human
Specificity
Human
Mouse, Rat (Species predicted to react based on 100% sequence homology)
Verified Activity
1. Immunochemical staining of human VEGFA in human liver with mouse monoclonal antibody(1:30, formalin-fixed paraffin embedded sections).
2. Immunochemical staining of human VEGFA in human hepatoma with mouse monoclonal antibody(1:30, formalin-fixed paraffin embedded sections).
Application
Recommended Dose
IHC-P: 1:20-1:100
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with a synthetic peptide corresponding to the C-terminus of the Human VEGF/VEGFA. The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundVascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF) and VEGF-A, is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is a member of the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family and often exists as a disulfide-linked homodimer. VEGF-A protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, inhibiting apoptosis and tumor growth. VEGF-A protein is also a vasodilator that increases microvascular permeability, thus it was originally referred to as vascular permeability factor.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
A synthetic peptide: C-terminus of the Human VEGF/VEGFA
Antigen Species
Human
Biology Area
Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-VEGFA Antibody (9C236) | purchase Anti-VEGFA Antibody (9C236) | Anti-VEGFA Antibody (9C236) cost | order Anti-VEGFA Antibody (9C236)